deguelin has been researched along with Melanoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carpenter, EL; Cassidy, PB; Chagani, S; Ganguli-Indra, G; Indra, AK; Laws, M; Nelson, D | 1 |
1 other study(ies) available for deguelin and Melanoma
Article | Year |
---|---|
Mitochondrial complex I inhibitor deguelin induces metabolic reprogramming and sensitizes vemurafenib-resistant BRAF
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Electron Transport Complex I; Humans; MAP Kinase Signaling System; Mechanistic Target of Rapamycin Complex 1; Melanoma; Mitogen-Activated Protein Kinases; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Rotenone; Signal Transduction; Vemurafenib | 2019 |